首页 | 本学科首页   官方微博 | 高级检索  
     


Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomes
Authors:Katherine L. Palmerola  Jennifer Y. Hsu  Lisa C. Grossman  Mark V. Sauer  Roger A. Lobo
Affiliation:1. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility and;2. Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Abstract:No significant differences in outcomes have been found between protocols of endometrial preparation for frozen embryo transfer (FET), though gonadotropin releasing hormone (GnRH) antagonists may have detrimental effects on the endometrium. We conducted a retrospective cohort noninferiority study at a single academic center of women receiving multiple doses of mid-cycle GnRH antagonist (GAnt) to those receiving GnRH agonist (GAg) to determine if there are detrimental effects of GnRH antagonists. 1047 FET cycles were identified, detailed data was available in 840 cycles: 610 GAg and 230 GAnt cycles. Patients undergoing GAnt cycles were older (40?±?6.6 versus 37?±?5.1 years, p?p?p?=?0.0009). Clinical pregnancy rates (CPRs) per transfer and implantation rates (IRs) were similar for GAnt and GAg cycles. There was a trend for higher pregnancy and IRs with GAg cycles in younger women (CPR 38.8% versus 26.7%, p?=?0.16; IR 36% versus 23.3%, p?=?0.07). Stratifying by diagnosis, CPR and IR were similar in GAnt and GAg cycles. A GAnt protocol of endometrial preparation for FET is not inferior to a GAg protocol regardless of patient age, use of donor oocyte, or infertility diagnosis.
Keywords:Endometrial preparation  frozen embryo transfer  GnRH antagonist  GnRH agonist  pregnancy outcome
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号